|
Histone H4K16, H4K5, H4K12 acetylation
|
|
MSL3
|
207551_s_at
|
male-specific lethal 3 homolog
|
0.0002
|
1.65
|
|
MSL1
|
224765_at
|
male-specific lethal 1 homolog
|
<0.0001
|
1.60
|
|
KAT8
|
221820_s_at
|
lysine acetyltransferase 8
|
0.0187
|
1.38
|
|
BRD4
|
226052_at
|
bromodomain containing 4
|
0.0003
|
1.38
|
|
ING4
|
218234_a
|
inhibitor of growth family, member 4
|
<0.0001
|
−2.05
|
|
Histone H3K4 methylation
|
|
MLL3
|
222415_at
|
myeloid/lymphoid or mixed-lineage leukemia 3
|
<0.0001
|
1.53
|
|
MLL2
|
231974_at
|
myeloid/lymphoid or mixed-lineage leukemia 2
|
0.0003
|
1.51
|
|
MLL4
|
203419_at
|
myeloid/lymphoid or mixed-lineage leukemia 4
|
0.0107
|
1.26
|
|
RTF1
|
212302_at
|
Rtf1, Paf1/RNA polymerase II complex component
|
0.0409
|
1.24
|
|
BCOR
|
223566_s_at
|
BCL6 corepressor
|
<0.0001
|
−1.74
|
|
KDM1A
|
212348_s_at
|
lysine-specific demethylase 1A
|
0.0002
|
−1.57
|
|
C14orf169
|
219526_at
|
lysine-specific demethylase NO66
|
0.0002
|
−1.34
|
|
Histone H3K14 acetylation
|
|
BRD4
|
226052_at
|
bromodomain containing 4
|
0.0003
|
1.38
|
|
Histone H3K36 methylation
|
|
NSD1
|
225654_at
|
nuclear receptor binding SET domain protein 1
|
0.0208
|
1.34
|
|
BCOR
|
223566_s_at
|
BCL6 corepressor
|
<0.0001
|
−1.74
|
|
C14orf169
|
219526_at
|
lysine-specific demethylase NO66
|
0.0002
|
−1.34
|
|
Histone H3K9 methylation
|
|
EHMT1
|
222873_s_at
|
euchromatic histone-lysine N-methyltransferase 1
|
0.0084
|
−1.41
|
|
EHMT2
|
202326_at
|
euchromatic histone-lysine N-methyltransferase 2
|
0.0013
|
−1.44
|
|
ARID4B
|
212591_at
|
AT rich interactive domain 4B (RBP1-like)
|
<0.0001
|
−1.51
|
|
Histone H4K20 methylation
|
|
ARID4B
|
212591_a
|
AT rich interactive domain 4B (RBP1-like)
|
<0.0001
|
−1.51
|
|
DNA methylation
|
|
DNMT1
|
201697_s_at
|
DNA (cytosine-5-)-methyltransferase 1
|
<0.0001
|
−2.03
|
